TA-MSCs can secrete a large amount of CXCL12 to activate the overexpressed specific receptor CXCR4 on AML cells, thereby guiding AML cells to migrate to the BMME and acquire drug resistance signals (196). This evidence concerns the gene CXCR4 and acute myeloid leukemia.